Non-Nutrient/Non-Botanical

NAC N-Acetyl-L-Cysteine

by Allergy Research Group · Tablet or Pill

Supplement facts from the label of NAC N-Acetyl-L-Cysteine by Allergy Research Group: N-Acetyl Cysteine 500 mg.

Label of NAC N-Acetyl-L-Cysteine, Allergy Research Group
Label image: NIH DSLD · full label (PDF)
Serving size1 Tablet(s)
Servings per container120
Most servings a day on the label3
TypeNon-Nutrient/Non-Botanical
Barcode713947713703
Label recordDSLD 304262 · entered 2024-01-24

Supplement Facts

IngredientPer serving% DVUpper limit (adults)
N-Acetyl Cysteine500 mg——

Upper limits: NIH ODS Fact Sheets for Health Professionals. Compared only where the unit converts and the limit applies to the form on the label.

On the label

For: Adult (18 - 50 Years)

Claim types: All Other · Structure/Function

Formula re: Contains: NAC N-Acetyl-L-Cysteine NAC, the acetyl derivative of L-cysteine, is more stable than L-cysteine, and can convert into L-cysteine after being absorbed. Free form amino acid, high purity, well tolerated, and in tablet form to insure potency.

Suggested/Recommended/Usage/Directions: Suggested Use As a dietary supplement, 1 tablet one to three times daily, or as directed by a healthcare practitioner.

Storage: Keep in a cool, dry place, tightly capped.

FDA Disclaimer Statement: This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Formulation re: Other: Glutathione Precursor

Formulation re: Other: Hypoallergenic

This page repeats what the label says and the official upper limits for healthy adults. It is not medical advice: ask a doctor, pharmacist or registered dietitian about your own intake, especially if you are pregnant, take medicines or have a health condition.

Label data: NIH Office of Dietary Supplements, Dietary Supplement Label Database (dsld.od.nih.gov), public domain. Upper limits: NIH ODS Fact Sheets for Health Professionals (values from the Institute of Medicine, Food and Nutrition Board).